Entresto

Entresto (generic names: sacubitril & valsartan) was the first and only therapy approved in the US in 2021 to treat both patients diagnosed with heart failure with reduced ejection fraction (HFrEF) as well as many with heart failure with preserved ejection fraction (HFpEF). It is an oral medication that is prescribed to treat people with chronic heart failure who are in danger of needing to be hospitalized when symptoms get worse. It also helps lower the risk of death from heart failure. Entresto is usually given together with other blood pressure medications.
Sacubitril is a blood pressure medicine that works by reducing sodium levels in the blood.
Valsartan is an angiotensin II receptor blocker (ARB) medication that keeps blood vessels from narrowing. Together, these lower blood pressure and improve blood flow. Dosage Your doctor will prescribe the appropriate dose. Entresto can be taken with or without food.
The recommended starting dose is usually one tablet of 50 mg or 100 mg twice a day (one tablet in the morning and one tablet in the evening). Your doctor will decide your exact starting dose based on which medicines you were taking previously and your blood pressure. Your doctor will then adjust the dose every 2-4 weeks depending on how you respond to the treatment until the best dose for you is found. The usual recommended target dose is 200 mg twice a day (one tablet in the morning and one tablet in the evening).
If one dose is missed and can be taken within a few hours of the scheduled time, it can be taken then. However, do not double-dose later to make up for a missed dose.